ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
30.50
+0.15 (0.49%)
Jun 8, 2026, 4:00 PM EDT - Market closed
ArriVent BioPharma Employees
ArriVent BioPharma had 77 employees as of December 31, 2025. The number of employees increased by 25 or 48.08% compared to the previous year.
Employees
77
Change (1Y)
25
Growth (1Y)
48.08%
Revenue / Employee
n/a
Profits / Employee
-$1,886,247
Market Cap
1.42B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 77 | 25 | 48.08% |
| Dec 31, 2024 | 52 | 12 | 30.00% |
| Dec 31, 2023 | 40 | - | - |
| Sep 30, 2023 | 42 | - | - |
| Jun 30, 2023 | 40 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immunocore Holdings | 524 |
| Ardelyx | 489 |
| Vir Biotechnology | 367 |
| KalVista Pharmaceuticals | 275 |
| Monte Rosa Therapeutics | 187 |
| Maze Therapeutics | 141 |
| Septerna | 130 |
| AnaptysBio | 104 |
AVBP News
- 10 days ago - ArriVent Biopharma assumed with a Buy at Truist - TheFly
- 27 days ago - ArriVent Biopharma price target lowered to $43 from $45 at Citi - TheFly
- 4 weeks ago - ArriVent Biopharma reports Q1 EPS (96c), consensus (89c) - TheFly
- 4 weeks ago - ArriVent BioPharma Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 4 weeks ago - ArriVent BioPharma Earnings release: Q1 2026 - Filings
- 4 weeks ago - ArriVent BioPharma Quarterly report: Q1 2026 - Filings
- 4 weeks ago - ArriVent BioPharma Slides: Corporate presentation - Filings
- 4 weeks ago - ArriVent Biopharma announces FDA clearance of ARR-002 NDA - TheFly